[go: up one dir, main page]

GB2564515B - Pharmaceutical composition and a method for manufacturing the same - Google Patents

Pharmaceutical composition and a method for manufacturing the same Download PDF

Info

Publication number
GB2564515B
GB2564515B GB1805951.9A GB201805951A GB2564515B GB 2564515 B GB2564515 B GB 2564515B GB 201805951 A GB201805951 A GB 201805951A GB 2564515 B GB2564515 B GB 2564515B
Authority
GB
United Kingdom
Prior art keywords
manufacturing
same
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1805951.9A
Other versions
GB201805951D0 (en
GB2564515A (en
Inventor
Ur Rehman Mahboob
Ahmad Waseem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eaststone Ltd
Original Assignee
Eaststone Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eaststone Ltd filed Critical Eaststone Ltd
Publication of GB201805951D0 publication Critical patent/GB201805951D0/en
Publication of GB2564515A publication Critical patent/GB2564515A/en
Application granted granted Critical
Publication of GB2564515B publication Critical patent/GB2564515B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1805951.9A 2017-04-10 2018-04-10 Pharmaceutical composition and a method for manufacturing the same Active GB2564515B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1705745.6A GB2561355A (en) 2017-04-10 2017-04-10 Pharmaceutical composition and a method for manufacturing the same

Publications (3)

Publication Number Publication Date
GB201805951D0 GB201805951D0 (en) 2018-05-23
GB2564515A GB2564515A (en) 2019-01-16
GB2564515B true GB2564515B (en) 2022-10-26

Family

ID=58744775

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1705745.6A Withdrawn GB2561355A (en) 2017-04-10 2017-04-10 Pharmaceutical composition and a method for manufacturing the same
GB1805951.9A Active GB2564515B (en) 2017-04-10 2018-04-10 Pharmaceutical composition and a method for manufacturing the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB1705745.6A Withdrawn GB2561355A (en) 2017-04-10 2017-04-10 Pharmaceutical composition and a method for manufacturing the same

Country Status (1)

Country Link
GB (2) GB2561355A (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060140989A1 (en) * 2004-12-22 2006-06-29 Schering Corporation Pharmaceutical formulations
US20080260837A1 (en) * 2007-04-20 2008-10-23 Qpharma, L.L.C. Physically stable aqueous suspensions of active pharmaceuticals
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20110015233A1 (en) * 2009-07-20 2011-01-20 Vetegen, Llc Stable Pharmaceutical Omeprazole Formulation for Oral Administration
WO2013192066A1 (en) * 2012-06-19 2013-12-27 Intercontinental Great Brands Llc Chewing gum product and method of production thereof
WO2014104412A1 (en) * 2012-12-28 2014-07-03 Otsuka Pharmaceutical Co., Ltd. Injectable depot formulation comprising optically active tolvaptan and process of producing the same
GB2513172A (en) * 2013-04-18 2014-10-22 Nupharm Lab Ltd Liquid dosage form and delivery system
US20140364392A1 (en) * 2013-06-06 2014-12-11 Novartis Ag Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
CN104523589A (en) * 2014-12-26 2015-04-22 万特制药(海南)有限公司 Oral suspension type medicine composition containing agomelatine
WO2017036118A1 (en) * 2015-08-31 2017-03-09 诺瑞特国际药业股份有限公司 Injectable aripiprazole suspension preparation having prolonged shelf life

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US8999395B2 (en) * 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
BR102012030828A2 (en) * 2012-12-03 2014-09-16 Ems Sa PHARMACEUTICAL COMPOSITION UNDERSTANDING DESLORATATIN AND PREDNISOLONE AND THEIR USE

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060140989A1 (en) * 2004-12-22 2006-06-29 Schering Corporation Pharmaceutical formulations
US20080260837A1 (en) * 2007-04-20 2008-10-23 Qpharma, L.L.C. Physically stable aqueous suspensions of active pharmaceuticals
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20110015233A1 (en) * 2009-07-20 2011-01-20 Vetegen, Llc Stable Pharmaceutical Omeprazole Formulation for Oral Administration
WO2013192066A1 (en) * 2012-06-19 2013-12-27 Intercontinental Great Brands Llc Chewing gum product and method of production thereof
WO2014104412A1 (en) * 2012-12-28 2014-07-03 Otsuka Pharmaceutical Co., Ltd. Injectable depot formulation comprising optically active tolvaptan and process of producing the same
GB2513172A (en) * 2013-04-18 2014-10-22 Nupharm Lab Ltd Liquid dosage form and delivery system
US20140364392A1 (en) * 2013-06-06 2014-12-11 Novartis Ag Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
CN104523589A (en) * 2014-12-26 2015-04-22 万特制药(海南)有限公司 Oral suspension type medicine composition containing agomelatine
WO2017036118A1 (en) * 2015-08-31 2017-03-09 诺瑞特国际药业股份有限公司 Injectable aripiprazole suspension preparation having prolonged shelf life

Also Published As

Publication number Publication date
GB201805951D0 (en) 2018-05-23
GB2561355A (en) 2018-10-17
GB2564515A (en) 2019-01-16
GB201705745D0 (en) 2017-05-24

Similar Documents

Publication Publication Date Title
IL323780A (en) D-homopregnane compounds and a pharmaceutical composition comprising them
IL266454B (en) Implant and method for forming the implant
PL3559344T3 (en) Method for manufacturing a packaging material and a packaging material made by the method
SG11202004253QA (en) Oil-and-fat composition and manufacturing method thereof
ZA201707520B (en) Bent member and manufacturing method for the same
EP3585511A4 (en) Metal-molybdate and method for making the same
PL3283551T3 (en) An activated lignin composition, a method for the manufacturing thereof and use thereof
GB201612960D0 (en) Pre-treament coating composition and a method for producing the same
PL3231784T3 (en) A layered tile and a method for manufacturing the layered tile
GB2537977B (en) A door and a method for manufacturing the same
GB2567619B (en) Pneumatic device and method for manufacturing the same
EP3263477A4 (en) Packaging material and method for manufacturing same
PT3802106T (en) Geocomposite and method for the production thereof
ZA201804964B (en) Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same
EP3285950A4 (en) Self brazing material and a method of making the material
ZA202000414B (en) Clutch and method for the production thereof
EP3424521A4 (en) Pharmaceutical composition and manufacturing method thereof
PL3484782T3 (en) Shelf-ready package and method for manufacturing the same
ZA201908090B (en) Pharmaceutical composition and method for preparing same
EP3244758A4 (en) Low-fructan grain material and a method for producing the same
PT3665183T (en) Method of manufacturing a pharmaceutical composition
GB201609412D0 (en) Self-sanitising compositions and method for the production thereof
GB2540133B (en) A condiment and a method for making the same
GB2564515B (en) Pharmaceutical composition and a method for manufacturing the same
HUE061661T2 (en) Electrode unit and method for manufacturing the same